University of Florida
Gainesville, FL
Wilson Sonsini partner Eva Yin will participate in a planning meeting on artificial intelligence and healthcare hosted by the National Science Foundation AHeAD Center, taking place May 13, 2026, at the University of Florida’s Straughn Center in Gainesville. The meeting is a collaborative effort among the University of Florida, Georgia Tech, Tulane University, and the University of Louisiana at Lafayette.
The NSF AHeAD event will feature an expanded group of faculty and organizations from Florida, with a focus on fostering meaningful interaction between industry leaders and academic experts. Participants will have a unique opportunity to influence future multi-million dollar research initiatives, gain early insights into cutting-edge AI-driven healthcare innovations, and connect with top universities and peer organizations. More details on this initiative are available here.
Jasper Vera
jvera@wsgr.com
Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.